Click on the links below to download the meeting report in Spanish or English. This report features session highlights, video clips and selected figures from the meeting.
Friday 15th June 2018, Hotel Emperador, Madrid, Spain
|10:30–11:10||Welcome - Prediction and prevention of type 1 diabetes in children||Luis Castaño|
|11:10–11:50||Diabetic ketoacidosis||Patricia Enes Romero|
|12:50–13:30||Chronic complications||Roque Cardona-Hernandez|
|14:30–15:30||Practical insulin treatment||Roque Cardona-Hernandez|
|15:45–17:15||Advances in technology for diabetes treatment||Patricia Enes Romero|
|17:15–17:30||Closing remarks||Luis Castaño|
Following this meeting, delegates will be able to:
- Estimate the risk of, and understand how to predict and possibly prevent, type 1 diabetes in children and adolescents
- Assess the risks of, and effectively manage, acute and chronic complications of type 1 diabetes
- Discuss the best treatment options, including new insulins and advanced technologies, for maintaining optimal glucose control
An application for CME accreditation of this event has been made to the Comisión de Formación Continuada de las Profesiones Sanitarias de la Comunidad de Madrid
Hotel Emperador, Gran Vía, 53, Madrid, Spain
Hospital Universitario Cruces – UPV/EHU – Biocruces, CIBERDEM – CIBERER
Professor Castaño completed his medical degree at the Oviedo University, Spain in 1979, and went on to gain his specialty in paediatrics from the Hospital Valdecilla in Santander, Spain. Between 1987 and 1990 he was a research fellow at the Harvard University Joslin Diabetes Center in Boston, USA and then went on to complete his PhD in Medicine at the University of the Basque Country in Bizkaia, Spain. More recently, he gained a Masters in Leadership and Science Management from the University Pompeu Fabra in Barcelona, Spain.
Until 2008, he held the role of vice-president of the Spanish Society of Diabetes. He was also the scientific director of CIBERDEM until 2014 and president of the Spanish Society for Paediatric Endocrinology (SEEP) until 2016. Currently, he is principal investigator of CIBERDEM and CIBERER.
Professor Castaño’s research interests include diabetes, genetics of endocrine diseases, disorders of sexual development, calcium/potassium alterations and genetics of endocrine neoplasia. He has contributed to 36 books and over 250 publications.
Dialibre Clínica de Diabetes y Nutrición, Madrid
She graduated with a degree in medicine from the Autonomous University of Madrid. She then studied for her speciality in paediatrics at the University of Alcalá in Madrid, followed by specialities in diabetes and paediatric endocrinology from the Ramón y Cajal Hospital also in Madrid. She has been part of the medical team at the Ramón y Cajal Hospital, the Infanta Sofía Hospital and the La Moraleja Hospital, and researcher at the Institute Ramón y Cajal for Health Research (IRYCIS) in the same city.
In 2013, she joined Medtronic as a therapy development specialist for Spain and Portugal, with the main objective of increasing access to technology for diabetes. Here, she was involved in the EQUIP programme, which involved the introduction of insulin pumps for the treatment of type 1 diabetes. The training of professionals in good practice and technology management was key to the success of the programme. Since 2014, more than 30 diabetes units have participated in the programme, as well as several endocrinology services, allowing them to offer better care to their patients with type 1 diabetes. It has also been recognised as a quality certification.
After several years of working in the field of diabetes, Dr Romero and María Seoane together founded the Dialibre Clinic in October 2015, with the aim of improving the quality of life and health outcomes of children and young people with diabetes through a model of care focused on improving the autonomy and satisfaction of patients and their families. The clinic specialises in the latest technologies, training models and innovative tools, as well as focusing on telemedicine and the psychological and emotional aspects of living with diabetes.
Dr Romero’s publications focus on the field of type 1 diabetes, diabetes related to cystic fibrosis, monogenic diabetes, obesity and metabolism, serious diseases and hypothyroidism. She has also contributed to a number of medical publications and international scientific congresses.
Hospital Regional Universitario de Málaga
Dr Leiva Gea is the first author of a publication on prevention of type 1 diabetes which has received two awards; one for ‘best communication’ from a prestigious Spanish congress and one for ‘good reception’ at a European congress. She is currently working on an investigative project in the area of microbiota and diabetes, education in diabetes as well as a project in the prevention of obesity in schools supported by the Spanish Academy of Paediatrics (AEP).
Hospital Sant Joan de Déu, Barcelona
His research interests include the impact of new technologies in paediatric diabetes and the study and prevention of diabetes complications early in childhood. Dr Cardona-Hernández is an author or co-author of several peer-reviewed papers in paediatric diabetes and is also an active member of the Spanish Society of Paediatric Endocrinology (SEEP), the Spanish Diabetes Society (SED), the International Society of Pediatric and Adolescent Diabetes (ISPAD) and the SWEET initiative for international centres of reference in paediatric diabetes.
This programme is made possible thanks to an independent educational grant from Novo Nordisk A/S.
Telephone +44 (0) 203 192 2023
Springer Healthcare IME
4 Crinan Street
London, N1 9XW, UK